Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Altynay Shigayeva

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
PLOS Global Public Health|March 24, 2023
Retention on ART and viral suppression among patients in alternative models of differentiated HIV service delivery in KwaZulu-Natal, South AfricaAltynay Shigayeva, Ntombi Gcwensa, Celiwe Dlamini Ndlovu, et al.
PLOS Global Public Health|March 8, 2024
Correction: Retention on ART and viral suppression among patients in alternative models of differentiated HIV service delivery in KwaZulu-Natal, South AfricaAltynay Shigayeva, Ntombi Gcwensa, Celiwe Dlamini Ndlovu, et al.
Scientific Reports|April 23, 2025
Enhancing tuberculosis (TB) case detection among hospitalized patients through lay health worker led screening: a before-and-after study in KwaZulu-Natal, South AfricaAbera Balcha Bulti, Asnake Yohannes Dumicho, Altynay Shigayeva, et al.
Vaccine|November 26, 2015
Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003-2011Altynay Shigayeva, Wallis Rudnick, Karen Green, et al.
The Journal of Infection|October 25, 2022
Viral dynamics of the SARS-CoV-2 Omicron Variant among household contacts with 2 or 3 COVID-19 vaccine dosesChristopher Kandel, Yaejin Lee, Maureen Taylor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2014
Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillanceStefan P Kuster, Wallis Rudnick, Altynay Shigayeva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2015
Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination ProgramsAltynay Shigayeva, Wallis Rudnick, Karen Green, et al.
BMC Infectious Diseases|February 8, 2025
Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort studyAltynay Shigayeva, Christopher Kandel, Lubna Farooqi, et al.
Vaccine|October 9, 2013
Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011Wallis Rudnick, Zhong Liu, Altynay Shigayeva, et al.
Plos One|May 27, 2010
Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, CanadaJanet Raboud, Altynay Shigayeva, Allison McGeer, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
PLOS Global Public Health|March 24, 2023
Retention on ART and viral suppression among patients in alternative models of differentiated HIV service delivery in KwaZulu-Natal, South AfricaAltynay Shigayeva, Ntombi Gcwensa, Celiwe Dlamini Ndlovu, et al.
PLOS Global Public Health|March 8, 2024
Correction: Retention on ART and viral suppression among patients in alternative models of differentiated HIV service delivery in KwaZulu-Natal, South AfricaAltynay Shigayeva, Ntombi Gcwensa, Celiwe Dlamini Ndlovu, et al.
Scientific Reports|April 23, 2025
Enhancing tuberculosis (TB) case detection among hospitalized patients through lay health worker led screening: a before-and-after study in KwaZulu-Natal, South AfricaAbera Balcha Bulti, Asnake Yohannes Dumicho, Altynay Shigayeva, et al.
Vaccine|November 26, 2015
Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003-2011Altynay Shigayeva, Wallis Rudnick, Karen Green, et al.
The Journal of Infection|October 25, 2022
Viral dynamics of the SARS-CoV-2 Omicron Variant among household contacts with 2 or 3 COVID-19 vaccine dosesChristopher Kandel, Yaejin Lee, Maureen Taylor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2014
Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillanceStefan P Kuster, Wallis Rudnick, Altynay Shigayeva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2015
Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination ProgramsAltynay Shigayeva, Wallis Rudnick, Karen Green, et al.
BMC Infectious Diseases|February 8, 2025
Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort studyAltynay Shigayeva, Christopher Kandel, Lubna Farooqi, et al.
Vaccine|October 9, 2013
Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011Wallis Rudnick, Zhong Liu, Altynay Shigayeva, et al.
Plos One|May 27, 2010
Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, CanadaJanet Raboud, Altynay Shigayeva, Allison McGeer, et al.
Pageof 3